A photo of Adam Lane.

Adam Lane, PhD


  • Member, Division of Bone Marrow Transplantation and Immune Deficiency
  • Assistant Professor, UC Department of Pediatrics

About

Biography

Dr. Lane joined Cincinnati Children's in July 2013. He has published novel statistical methods in the areas of adaptive and optimal experimental designs with applications to phase I and phase II clinical trials. As a graduate student he received funding from the NIH to spend the fall semester of 2011 at the University of Cambridge in the Isaac Newton Institute for Mathematical Sciences. He has also received NSF travel awards to present his research at national and international conferences.

Publications

Chemotherapy-induced thrombocytopenia in Ewing sarcoma: Implications and potential for romiplostim supportive care. Merjaneh, N; Young, J; Mangoli, A; Olsen, M; Setty, B; Lane, A; Nagarajan, R; Pressey, JG; Turpin, B. Pediatric Blood and Cancer. 2021.

A prospective pilot study of a novel alemtuzumab target concentration intervention strategy. Arnold, DE; Emoto, C; Fukuda, T; Dong, M; Vinks, AA; Lane, A; McIntosh, K; Neumeier, L; Lankester, AC; Achini, F; et al. Bone Marrow Transplantation. 2021; 56:3029-3031.

Graft rejection markers in children undergoing hematopoietic cell transplant for bone marrow failure. Sabulski, A; Myers, KC; Bleesing, JJ; Duell, A; Lane, A; Teusink-Cross, A; Davies, SM; Jodele, S. Blood Advances. 2021; 5:4594-4604.

An improved index for diagnosis and mortality prediction in malignancy associated hemophagocytic lymphohistiocytosis. Zoref-Lorenz, A; Murakami, J; Hofstetter, L; Iyer, SP; Alotaibi, AS; Mohamed, SF; Miller, PG; Guber, E; Weinstein, S; Yacobovich, J; et al. Blood. 2021.

NIMG-11. VOLUMETRIC ENDPOINTS IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG): COMPARISON TO CROSS-SECTIONAL MEASURES AND CORRELATION WITH OUTCOMES. Lazow, M; Nievelstein, M; Lane, A; Bandopadhayay, P; DeWire-Schottmiller, M; Fouladi, M; Glod, J; Greiner, R; Hoffman, L; Hummel, T; et al. Neuro-Oncology. 2021; 23:vi129-vi130.

Hydroxyurea Reduces the Transfusion Burden in Children with Sickle Cell Anemia: The Reach Experience. Power-Hays, A; Tomlinson, GA; Tshilolo, L; Santos, B; Williams, TN; Olupot-Olupot, P; McGann, PT; Aygun, B; Lane, A; Stuber, SE; et al. Blood. 2021; 138:11-11.

Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial. Rankine-Mullings, A; Reid, M; Soares, D; Taylor-Bryan, C; Wisdom-Phipps, M; Aldred, K; Latham, T; Schultz, WH; Knight-Madden, J; Badaloo, A; et al. British Journal of Haematology. 2021; 195:612-620.

Accuracy of Central Neuro-Imaging Review of DIPG Compared with Histopathology in the International DIPG Registry. Lazow, MA; Fuller, C; DeWire, M; Lane, A; Bandopadhayay, P; Bartels, U; Bouffet, E; Cheng, S; Cohen, KJ; Cooney, TM; et al. Neuro-Oncology. 2021.

α4β7 Integrin expression and blockade in pediatric and young adult gastrointestinal graft-versus-host disease. Ibrahimova, A; Davies, SM; Lane, A; Jordan, MB; Lake, K; Litts, B; Chaturvedi, V; Owsley, E; Myers, KC; Nelson, AS; et al. Pediatric Blood and Cancer. 2021; 68.

Prospective pilot trial of calcipotriene as a novel topical treatment for acute skin graft versus host disease. Wallace, G; Khandelwal, P; Myers, KC; Perentesis, EM R; Lane, A; Teusink-Cross, A; Smiley, K; Davies, SM; Jodele, S. Bone Marrow Transplantation. 2021; 56:1441-1444.